Gerresheimer at Taropak - innovative glass and plastic packaging products for new and traditional medications
Many of the special containers and application systems are manufactured by the company's Polish subsidiary, Gerresheimer Boleslawiec. This year, the production facility that Gerresheimer took over 15 years ago is celebrating its 60th anniversary.
Today, it is a highly specialised facility and the place where the Gerresheimer MultiShell® Vial, which won the German Packaging Award in 2011, was developed. The vials have an innovative design based on a combination of COP (Cyclic Olefin Polymer) and polyamide. The polyamide layer functions as an oxygen barrier that protects the oxidation-sensitive parenteral drug. The special multi-layer design of the MultiShell® vials with a polyamide core layer improves their safety and prevents leakages even when they are exposed to extraordinarily high mechanical loads.
"Demand is growing in Eastern Europe for high-quality, application-friendly system products. Our production plant in the Polish town of Boleslawiec enables us to bring our development and manufacturing operations close to our customers," said Michal Malkowski, CEO of Gerresheimer Boleslawiec.
The Tubular Glass Division is presenting a range of prefillable syringes, including its flagship RTF® sterile syringes. Tubular glass is the input material for a comprehensive range of high quality pharmaceutical vials, ampoules and cartridges in numerous filling sizes and design variants.
Gerresheimer Plastic Packaging specializes in plastic packaging products for the pharma industry. Its comprehensive product portfolio extends from plastic packaging products for solid pharmaceuticals such as drugs and powders to containers for liquid drugs, including ophthalmic and rhinological applications.
Gerresheimer is an internationally leading manufacturer of high-quality specialty products made of glass and plastic for the global pharma and healthcare industry. Our comprehensive portfolio of products extends from pharmaceutical vials to complex drug delivery systems such as syringe systems, insulin pens and inhalers for safe medication dosage and application. Together with our partners, we develop solutions which set standards and have role model status in their respective market sectors.
Our Group realizes revenues of more than one billion euros and has around 11,000 employees at 47 locations in Europe, North and South America and Asia. We use first-rate technologies, convincing innovations and targeted investments to systematically consolidate our strong market position.